STOCK TITAN

DNA (NYSE: DNA) Form 144: 13,116 Class A shares proposed sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Issuer reported a Form 144 notice for the proposed sale of 13,116 Class A shares under Rule 144. The shares arose from Restricted Stock Vesting dated 04/08/2026 and are held at Fidelity Brokerage Services LLC.

The filing lists prior sales of 13,155 Class A shares by Bartholomew Canton on 04/08/2026 and shows 49,941,878 shares outstanding as of 04/09/2026.

Positive

  • None.

Negative

  • None.

Insights

Routine Rule 144 notice for vested restricted shares; prior small sale noted.

The filing documents a proposed sale of 13,116 Class A shares tied to a Restricted Stock Vesting event on 04/08/2026. The broker of record is Fidelity Brokerage Services LLC.

Historical activity shows a sale of 13,155 shares on the same vesting date; shares outstanding are listed as 49,941,878 as of 04/09/2026. Cash‑flow treatment and buyer details are not included in the excerpt.

Proposed shares to sell 13,116 shares Restricted Stock Vesting on <date>04/08/2026</date>
Value shown for 13,116 shares $83,905.68 Associated with the 13,116 shares line
Shares sold in past 3 months 13,155 shares Sale by Bartholomew Canton on <date>04/08/2026</date>
Value shown for 13,155 shares $91,168.10 Associated with the 13,155 shares line
Shares outstanding 49,941,878 shares As of <date>04/09/2026</date>
Restricted Stock Vesting financial
"Class A | 04/08/2026 | Restricted Stock Vesting"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Fidelity Brokerage Services LLC other
"Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the DNA Form 144 disclose?

The Form 144 discloses a proposed sale of 13,116 Class A shares tied to a restricted stock vesting on 04/08/2026. It also lists a prior sale of 13,155 shares on the same date.

Who is the broker and how many shares are held at the broker for DNA?

The broker listed is Fidelity Brokerage Services LLC. The filing shows 13,116 Class A shares associated with that account from the vesting event dated 04/08/2026.

Does the Form 144 specify proceeds or sale price for DNA shares?

The excerpt provides monetary values next to share lines ($83,905.68 and $91,168.10) but does not state an explicit sale price per share or the receiving party for proceeds in the provided text.

How large is DNA's outstanding share count in this filing?

The filing shows 49,941,878 shares outstanding as of 04/09/2026. This figure appears on the securities information line in the excerpt.